Management - Spark Newswire

2 minute read

Short-Acting Psychedelics: DMT-Based Drug Therapy Gets Tested In New Clinical Trial

Today, 5:17 AM

Psychedelics biotech company Small Pharma Inc. (OTCQB: DMTTF) has dosed the first subject in its first-in-human clinical trial assessing proprietary DMT drug SPL028 paired with supportive therapy.

DMTTF

1 minute read

Roblox CFO Says Capex Related To Infrastructure Will Be Down Significantly In 2023, Somewhere Between 25%-30% Lower

By Happy Mohamed

Today, 5:17 AM

- Conf Call

RBLX

2 minute read

Salesforce Lays Out Harsher Policies Succumbing To Activist Pressure

By Anusuya Lahiri

Today, 5:17 AM

Salesforce, Inc (NYSE: CRM) weighed new ways to cut costs as activist investors pressured the company.

CRM

1 minute read

Elon Musk Earlier on Wednesday, Speaking Virtually At World Government Summit In Dubai, Said Towards The End Of 2023 Would Be A Good Time To Find Someone Else To Run Twitter

By Charles Gross

Today, 5:17 AM

-Reuters https://www.reuters.com/technology/elon-musk-says-end-2023-good-timing-find-new-twitter-head-2023-02-15/

TSLA

2 minute read

Electromed Announces Chief Executive Officer And President Retirement Of Kathleen Skarvan Effective date On Or Around July 1, 2023 And Succession Plan; Conducting A Comprehensive Search To Identify A New President And CEO And Engaged A National Executi…

By Happy Mohamed

Today, 5:17 AM

Electromed, Inc. (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan will retire as President and Chief Executive Officer with a target effective date on or around

ELMD

2 minute read

Psychedelics For Alcohol Use Disorder: Awakn Opens European Clinic, FSD Launches R&D Program

By Lara Goldstein

Today, 5:17 AM

Awakn Opens Fourth European Clinic, Norway Takes Center Stage

AWKNF

2 minute read

Cybin Reports Q3 Earnings, Says Psilocybin Tial Is Progressing As MDD Treatment

By Lara Goldstein

Today, 5:17 AM

Cybin Inc. (NYSE: CYBN) has shared its unaudited financial results for the third quarter that ended Dec. 31, 2022. The company held total cash of $16.9 (CA$22.5) million as of Dec. 31, 2022, and $15 million as of Feb. 14, 2023.

CYBN

1 minute read

NTSB On OH Train Derailment “NTSB investigators have identified and examined the rail car that initiated the derailment. Surveillance video from a residence showed what appears to be a wheel bearing in the final stage of overheat failure moments before…

By Happy Mohamed

Today, 5:17 AM

https://twitter.com/EvanLambertTV/status/1625564075412361216

NSC

2 minute read

Health Canada Grants Exemption: Phase 2 Trial On Psilocybin For Genetic Disorder

By Lara Goldstein

Today, 5:17 AM

Wellbeing Digital (OTC: KONEF) subsidiary KGK Sciences will advance with the first-ever Phase 2a clinical trial assessing repetitive, oral microdose psilocybin therapy for Fragile X Syndrome (FXS), a genetic disorder.

KONEF

1 minute read

Tim Hortons Parent Restaurant Brands Drops On Q4 Bottom-Line Miss; Names New CEO

By Shivani Kumaresan

Today, 5:17 AM

Restaurant Brands International Inc (NYSE:QSR) reported fourth-quarter sales growth of 9.3% year-on-year to $1.69 billion, beating the consensus of $1.67 billion.…

QSR